961.14 (4) (wb) 4-chloro-2,5-dimethoxyamphetamine, commonly known as DOC.
351,11
Section
11. 961.14 (4) (wk) of the statutes is created to read:
961.14 (4) (wk) 2,5-dimethoxy-4-ethylphenethylamine, commonly known as 2C-E.
351,12
Section
12. 961.14 (4) (wL) of the statutes is created to read:
961.14 (4) (wL) 2,5-dimethoxy-4-methylphenethylamine, commonly known as 2C-D.
351,13
Section
13. 961.14 (4) (wm) of the statutes is created to read:
961.14 (4) (wm) 2,5-dimethoxy-4-chlorophenethylamine, commonly known as 2C-C.
351,14
Section
14. 961.14 (4) (wn) of the statutes is created to read:
961.14 (4) (wn) 2,5-dimethoxy-4-ethylthiophenethylamine, commonly known as 2C-T-2.
351,15
Section
15. 961.14 (4) (wo) of the statutes is created to read:
961.14 (4) (wo) 2,5-dimethoxy-4-isopropylthiophenethylamine, commonly known as 2C-T-4.
351,16
Section
16. 961.14 (4) (wp) of the statutes is created to read:
961.14 (4) (wp) 2,5-dimethoxyphenethylamine, commonly known as 2C-H.
351,17
Section
17. 961.14 (4) (wq) of the statutes is created to read:
961.14 (4) (wq) 2,5-dimethoxy-4-nitrophenethylamine, commonly known as 2C-N.
351,18
Section
18. 961.14 (4) (wr) of the statutes is created to read:
961.14 (4) (wr) 2,5-dimethoxy-4-(n)-propylphenethylamine, commonly known as 2C-P.
351,19
Section
19. 961.14 (4) (ws) of the statutes is created to read:
961.14 (4) (ws) Any compound structurally derived from N-benzyl-2-(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen atom, or on either ring, with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, halide or nitro substituents, or by any combination of these modifications. Substances specified under this paragraph include:
1. 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25I-NBOMe.
2. 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25C-NBOMe.
3. 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25B-NBOMe.
4. 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, commonly known as 25E-NBOMe.
351,20
Section
20. 961.14 (4) (wv) of the statutes is created to read:
961.14 (4) (wv) N,N-diallyl-5-methoxytryptamine, commonly known as 5-MeO-DALT.
351,21
Section
21. 961.14 (4) (ww) of the statutes is created to read:
961.14 (4) (ww) 5-(2-aminopropyl)benzofuran, commonly known as 5-APB.
351,22
Section
22. 961.14 (4) (wx) of the statutes is created to read:
961.14 (4) (wx) 6-(2-aminopropyl)benzofuran, commonly known as 6-APB.
351,23
Section
23. 961.14 (4) (wy) of the statutes is created to read:
961.14 (4) (wy) 5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 5-APDB.
351,24
Section
24. 961.14 (4) (wz) of the statutes is created to read:
961.14 (4) (wz) 6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 6-APDB.
351,25
Section
25. 961.14 (4) (xa) of the statutes is created to read:
961.14 (4) (xa) 5-iodo-2-aminoindane, commonly known as 5-IAI.
351,26
Section
26. 961.14 (4) (xb) of the statutes is created to read:
961.14 (4) (xb) 4-methoxymethamphetamine, commonly known as PMMA.
351,27
Section
27. 961.14 (7) (intro.) of the statutes is amended to read:
961.14 (7) Stimulants. (intro.) Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their precursors, analogs, salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
351,28
Section
28. 961.14 (7) (L) of the statutes is repealed and recreated to read:
961.14 (7) (L) Substituted cathinones. Any compound, except bupropion or compounds scheduled elsewhere in this chapter, that is structurally derived from 2-amino-propan-1-one by substitution at the 1-position with either phenyl, napthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; by substitution at the 3-position with an acyclic alkyl substituent; by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a cyclic structure; or by any combination of these modifications. Substances specified under this subdivision include:
1. Methcathinone.
2. Methylenedioxypyrovalerone, commonly known as MDPV.
3. 4-methylmethcathinone, commonly known as mephedrone or 4-MMC.
4. 4-methylethcathinone, commonly known as 4-MEC.
5. 4-methoxy-alpha-pyrrolidinopropiophenone, commonly known as MOPPP.
6. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone, commonly known as MDPPP.
7. Alpha-pyrrolidinovalerophenone, commonly known as alpha-PVP.
8. 2-fluoromethcathinone, commonly known as 2-FMC.
9. 3-fluoromethcathinone, commonly known as 3-FMC.
10. 4-fluoromethcathinone, commonly known as 4-FMC or flephedrone.
11. 3,4-methylenedioxymethcathinone, commonly known as methylone or bk-MDMA.
12. Naphthylpyrovalerone, commonly known as naphyrone.
13. 4-methyl-alpha-pyrrolidinobutiophenone, commonly known as MPBP.
14. 4-methoxymethcathinone, commonly known as methedrone or bk-PMMA.
15. Ethcathinone.
16. 3,4-methylenedioxyethcathinone, commonly known as ethylone or bk-MDEA.
17. beta-Keto-N-methylbenzodioxolylbutanamine, commonly known as butylone or bk-MBDB.
18. N,N-dimethylcathinone, commonly known as metamfepramone.
19. Alpha-pyrrolidinopropiophenone, commonly known as alpha-PPP.
20. 3-methoxymethcathinone, commonly known as 3-MMC.
21. 4-ethylmethcathinone, commonly known as 4-EMC.
22. 3,4-dimethylmethcathinone, commonly known as 3,4-DMMC.
23. beta-Keto-N-methylbenzodioxolylpentanamine, commonly known as pentylone or bk-MBDP.
24. beta-Keto-ethylbenzodioxolylbutanamine, commonly known as eutylone or bk-EBDB.
25. 4-bromomethcathinone, commonly known as 4-BMC.
26. Alpha-methylamino-butyrophenone, commonly known as buphedrone or MABP.
27. 3,4-methylenedioxy-alpha-pyrrolidinobutiophenone, commonly known as MDPBP.
28. 4-methyl-alpha-pyrrolidinohexiophenone, commonly known as MPHP.
29. N,N-dimethyl-3,4-methylenedioxycathinone.
30. N,N-diethyl-3,4-methylenedioxycathinone.
31. Alpha-methylamino-valerophenone, commonly known as pentedrone.
351,29
Section
29. 961.14 (7) (m) and (n) of the statutes are repealed.
351,30
Section
30. 961.14 (7) (mk) of the statutes is created to read:
961.14 (7) (mk) Mitragynine.
351,31
Section
31. 961.14 (7) (mL) of the statutes is created to read:
961.14 (7) (mL) 7-hydroxymitragynine.
351,32
Section
32. 961.14 (7) (mm) of the statutes is created to read:
961.14 (7) (mm) 5,6-methylenedioxy-2-aminoindane, commonly known as MDAI.
351,33
Section
33. 961.14 (7) (mn) of the statutes is created to read:
961.14 (7) (mn) Benzothiophenylcyclohexylpiperidine, commonly known as BTCP.
351,34
Section
34. 961.16 (3) (tb) of the statutes is created to read:
961.16 (3) (tb) Oripavine.
351,35
Section
35. 961.16 (3) (zt) of the statutes is created to read:
961.16 (3) (zt) Tapentadol.
351,36
Section
36. 961.16 (8) (b) of the statutes is created to read:
961.16 (8) (b) An immediate precursor to fentanyl, including 4-anilino-N-phenethyl-4-piperidine, commonly known as ANPP.
351,37
Section
37. 961.18 (7) (am) of the statutes is created to read:
961.18 (7) (am) 19-Nor-4,9(10)-androstadienedione;
